Penny Stocks To Add to Your Watchlist – August 20th

Tharimmune, Rocket Pharmaceuticals, NovaBay Pharmaceuticals, Direxion Daily NVDA Bear 1X Shares, Auddia, Ondas, and Trinity Biotech are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of small companies that trade at low prices—typically under $5 per share according to U.S. Securities and Exchange Commission guidelines. They usually trade on over-the-counter markets, and their low liquidity and minimal regulatory requirements make them highly volatile and risky investments. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Tharimmune (THAR)

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1).

Read Our Latest Research Report on THAR

Rocket Pharmaceuticals (RCKT)

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

Read Our Latest Research Report on RCKT

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.

Read Our Latest Research Report on NBY

Direxion Daily NVDA Bear 1X Shares (NVDD)

Read Our Latest Research Report on NVDD

Auddia (AUUD)

Auddia Inc., a technology company, develops AI Platform for the audio and podcast markets. The company's flagship product is faidr, which enables consumers to listen to various AM/FM radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather.

Read Our Latest Research Report on AUUD

Ondas (ONDS)

Ondas Holdings Inc., through its subsidiaries, provides private wireless, drone, and automated data solutions. It operates in two segments, Ondas Networks and Ondas Autonomous Systems. The company designs, develops, manufactures, sells, and supports FullMAX, a software defined radio (SDR) platform for wide-area broadband networks.

Read Our Latest Research Report on ONDS

Trinity Biotech (TRIB)

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.

Read Our Latest Research Report on TRIB

See Also